Cargando…
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapit...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620584/ https://www.ncbi.nlm.nih.gov/pubmed/26493500 http://dx.doi.org/10.1038/ncomms9715 |
_version_ | 1782397320106606592 |
---|---|
author | Freedman, Benjamin S. Brooks, Craig R. Lam, Albert Q. Fu, Hongxia Morizane, Ryuji Agrawal, Vishesh Saad, Abdelaziz F. Li, Michelle K. Hughes, Michael R. Werff, Ryan Vander Peters, Derek T. Lu, Junjie Baccei, Anna Siedlecki, Andrew M. Valerius, M. Todd Musunuru, Kiran McNagny, Kelly M. Steinman, Theodore I. Zhou, Jing Lerou, Paul H. Bonventre, Joseph V. |
author_facet | Freedman, Benjamin S. Brooks, Craig R. Lam, Albert Q. Fu, Hongxia Morizane, Ryuji Agrawal, Vishesh Saad, Abdelaziz F. Li, Michelle K. Hughes, Michael R. Werff, Ryan Vander Peters, Derek T. Lu, Junjie Baccei, Anna Siedlecki, Andrew M. Valerius, M. Todd Musunuru, Kiran McNagny, Kelly M. Steinman, Theodore I. Zhou, Jing Lerou, Paul H. Bonventre, Joseph V. |
author_sort | Freedman, Benjamin S. |
collection | PubMed |
description | Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications. |
format | Online Article Text |
id | pubmed-4620584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46205842015-12-08 Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids Freedman, Benjamin S. Brooks, Craig R. Lam, Albert Q. Fu, Hongxia Morizane, Ryuji Agrawal, Vishesh Saad, Abdelaziz F. Li, Michelle K. Hughes, Michael R. Werff, Ryan Vander Peters, Derek T. Lu, Junjie Baccei, Anna Siedlecki, Andrew M. Valerius, M. Todd Musunuru, Kiran McNagny, Kelly M. Steinman, Theodore I. Zhou, Jing Lerou, Paul H. Bonventre, Joseph V. Nat Commun Article Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications. Nature Pub. Group 2015-10-23 /pmc/articles/PMC4620584/ /pubmed/26493500 http://dx.doi.org/10.1038/ncomms9715 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Freedman, Benjamin S. Brooks, Craig R. Lam, Albert Q. Fu, Hongxia Morizane, Ryuji Agrawal, Vishesh Saad, Abdelaziz F. Li, Michelle K. Hughes, Michael R. Werff, Ryan Vander Peters, Derek T. Lu, Junjie Baccei, Anna Siedlecki, Andrew M. Valerius, M. Todd Musunuru, Kiran McNagny, Kelly M. Steinman, Theodore I. Zhou, Jing Lerou, Paul H. Bonventre, Joseph V. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title | Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title_full | Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title_fullStr | Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title_full_unstemmed | Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title_short | Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids |
title_sort | modelling kidney disease with crispr-mutant kidney organoids derived from human pluripotent epiblast spheroids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620584/ https://www.ncbi.nlm.nih.gov/pubmed/26493500 http://dx.doi.org/10.1038/ncomms9715 |
work_keys_str_mv | AT freedmanbenjamins modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT brookscraigr modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT lamalbertq modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT fuhongxia modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT morizaneryuji modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT agrawalvishesh modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT saadabdelazizf modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT limichellek modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT hughesmichaelr modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT werffryanvander modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT petersderekt modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT lujunjie modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT bacceianna modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT siedleckiandrewm modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT valeriusmtodd modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT musunurukiran modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT mcnagnykellym modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT steinmantheodorei modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT zhoujing modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT leroupaulh modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids AT bonventrejosephv modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids |